Novel Opportunities in the Treatment and Prevention of Scarring
- 1 December 2004
- journal article
- review article
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 8 (S3) , 32-36
- https://doi.org/10.1007/s10227-004-0806-0
Abstract
Numerous treatments have been described for the treatment and prevention of scars, but the optimal management strategy is yet to be defined. In this article we present and evaluate new opportunities for the treatment and prevention of hypertrophic scars, keloids, and atrophic scars. Clinical, animal, and in vitro studies reporting novel techniques for the treatment and prevention of scarring were identified primarily from the MEDLINE/PubMed database. We found that a variety of new treatments exist with potential effectiveness for the treatment of hypertrophic scars and keloids, including interferon, imiquimod 5% cream, tacrolimus, botulinum toxin, 5-fluorouracil, bleomycin, and verapamil. For atrophic scars, different types of lasers represent modern treatment modalities with satisfactory results. Several agents have been reported to be effective in reducing scarring in vitro and in animal studies, representing potential opportunities for scarring management. We conclude that several novel modalities may be potential therapies for scarring.Keywords
This publication has 40 references indexed in Scilit:
- Chemoimmobilization: Improving Predictability in the Treatment of Facial ScarsPlastic and Reconstructive Surgery, 2003
- Novel antisense oligonucleotides targeting TGF-β inhibit in vivo scarring and improve surgical outcomeGene Therapy, 2003
- Are keloids really “gli-loids”?: High-level expression of gli-1 oncogene in keloidsJournal of the American Academy of Dermatology, 2001
- Postacne Scarring: A Review of its Pathophysiology and TreatmentDermatologic Surgery, 2000
- Keloids and Hypertrophic ScarsDermatologic Surgery, 1999
- Interferon‐γ inhibits the myofibroblastic phenotype of rat palatal fibroblasts induced by transforming growth factor‐β1 in vitroFEBS Letters, 1999
- Angiotensin II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblastsJournal of Molecular and Cellular Cardiology, 1995
- Modulation of Collagen Synthesis by Transforming Growth Factor-β in Keloid and Hypertrophic Scar FibroblastsAnnals of Plastic Surgery, 1994
- Growth Factors and Wound HealingScandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, 1994
- Role of transforming growth factor-beta 1 in the cellular growth response to angiotensin II.Hypertension, 1993